소장자료

Drugs for HER-2-positive Breast Cancer [electronic resource]

  • Sibilia, Maria. editor. , Zielinski, Christoph C. editor. , Bartsch, Rupert. editor. , Grunt, Thomas W. editor.
  • 2011
Drugs for HER-2-positive Breast Cancer [electronic resource]
  • 자료유형
    단행본
  • 서명/저자사항
    Drugs for HER-2-positive Breast Cancer[electronic resource] / edited by Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas W. Grunt.
  • 개인저자
    Sibilia, Maria., editor., Zielinski, Christoph C., editor., Bartsch, Rupert., editor., Grunt, Thomas W., editor.
  • 단체저자
    SpringerLink (Online service)
  • 형태사항
    X, 110 p. : online resource.
  • 총서명
    Milestones in Drug Therapy
  • 내용주기
    Drugs for HER-2-positive Breast Cancer: A Major Approval for Translational Cancer Research (Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas Grunt) -- The EGFR/ErbB family in breast cancer: from signaling to therapy (Wolfgang J. K철stler and Yosef Yarden) -- Trastuzumab as Adjuvant treatment for early stage HER-2 positive breast cancer (Rupert Bartsch and Guenther G. Steger) -- Trastuzumab Resistance in breast cancer (Floriana Morgillo, Michele Orditura, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Fortunato Ciardiello) -- Treatment with Trastuzumab beyond Progression (Gunter von Minckwitz and Cristina Pirvulescu) -- Pertuzumab ??a HER-2 dimerisation inhibitor ??for the treatment of breast and other cancers (Giulia Bianchi and Luca Gianni) -- Beyond trastuzumab: Second generation targeted therapies for HER2--positive breast cancer (Flavio F. Solca, Guenther R. Adolf, Hilary Jones, Martina M. Uttenreuther-Fischer).
  • 일반주제명
    Medicine.
    Cancer research.
    Immunology.
    Antibodies.
    Pharmacology.
    Internal medicine.
    Oncology.
    Biomedicine.
    Pharmacology/Toxicology.
    Oncology.
    Cancer Research.
    Antibodies.
    Immunology.
    Internal Medicine.
  • 기본자료 저록
    Springer eBooks
  • 기타형태 저록
    Printed edition: 9783034600934
  • ISBN
    9783034600941
  • 언어
    영어